Page 6 - Arbutus Branch News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Arbutus branch. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Arbutus Branch Today - Breaking & Trending Today

Arbutus to Present AB-729 and AB-161 Data at the Global

Two oral presentations scheduled for Thursday, April 27, 2023 WARMINSTER, Pa., April 18, 2023 (GLOBE NEWSWIRE) Arbutus Biopharma Corporation (Nasdaq:. ....

France General , United States , N Acetylgalactosamine Galnac , Lisam Caperelli , Fung Yuen , World Health Organization , Arbutus Biopharma Corporation Nasdaq , Securities Exchange , Biopharma Corporation , Global Hepatitis Summit , Late Breaker Abstracts , Looking Statements , Securities Act , Securities Exchange Act , Arbutu Annual Report , Arbutu Quarterly Reports , Nasdaq Abus , Arbutus Biopharma Corporation , Arbutus Biopharma , Abstracts Accepted , Global Hepatitis Summit ,

Moderna fends off Arbutus appeal in COVID-19 vaccine patent fight

A U.S. appeals court handed Moderna Inc a win on Tuesday, affirming a decision to cancel an Arbutus Biopharma Corp patent related to the companies legal fight over Moderna s blockbuster COVID-19. | April 11, 2023 ....

United States , United Kingdom , Blake Brittain , Genevant Sciences , Roivant Sciences Ltd , Us Court , Modernatx Inc , Trademark Office , Arbutus Biopharma Corp , Federal Circuit , Appeal Board , Roivant Sciences , Pennsylvania Based Arbutus , Massachusetts Based Moderna , Arbutus Biopharma Corporation Stock Exchange , Press Release , Lockbuster Abus Ca03879j1003 ,

Health News Roundup: Bayer defeats Merck in lawsuit over talc liabilities; Gilead details promising early COVID antiviral data, setting up larger studies and more

Vice Chancellor Nathan Cook of the Delaware Chancery Court said the purchase agreement "clearly and unambiguously" left Merck liable for claims related to products, including Dr. Scholl's foot powder, sold before the transaction closed. Gilead details promising early COVID antiviral data, setting up larger studies Gilead Sciences Inc on Tuesday unveiled data from the first human study of its experimental oral COVID-19 antiviral, saying the results in healthy volunteers cleared the way for two large Phase III trials of the drug that have begun enrolling patients. ....

United States , New Jersey , Robert Habeck , Nathan Cook , Peter Goldschmidt , Us Justice Department On , Drug Administration , Gilead Sciences Inc On , Pfizer Inc , Merck Co , Genevant Sciences , Department Of Corrections , Delaware Chancery Court , Bayer Ag , Chancellor Nathan Cook , Sciences Inc , Baby Powder , German Economy Minister Robert Habeck , Nathan Cook , Xclusive Germany 39 S , Erck Amp Co 39 S , Hapter 11 , Pfizer Inc , Bill Gates ,

Arbutus Biopharma Sues Pfizer, BioNTech Over Alleged Patent Infringement

By Will Feuer

Arbutus Biopharma Corp. and its licensee Genevant Sciences have filed a patent-infringement lawsuit against Pfizer Inc. and BioNTech SE related to the latter s Covid-19 vaccine.. | April 4, 2023 ....

William Collier , Genevant Sciences , Arbutus Biopharma Corp , Pfizer Inc , Will Feuer , Biopharma Chief Executive William Collier , Dow Jones , Arbutus Biopharma Corporation Stock Exchange , Press Release , He Abus Ca03879j1003 ,

Arbutus Biopharma Sues Pfizer, BioNTech Over Alleged Patent Infringement -- Update

By Will Feuer

Arbutus Biopharma Corp. and its licensee Genevant Sciences have filed a patent-infringement lawsuit against Pfizer Inc. and BioNTech SE related to the latter s Covid-19 vaccine.. | April 4, 2023 ....

William Collier , Pfizer Inc , Genevant Sciences , Arbutus Biopharma Corp , Will Feuer , Biopharma Chief Executive William Collier , Arbutus Biopharma , Dow Jones , Arbutus Biopharma Corporation Stock Exchange , Press Release , He Abus Ca03879j1003 ,